Alberto Fulvi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study.

Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study.

Journal: NPJ breast cancer
Published: January 23, 2026

Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.

Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.

Journal: Biology direct
Published: May 02, 2025

Adherence to Aromatase Inhibitor Therapy in Breast Cancer: Insights From a Multicenter Italian Study.

Adherence to Aromatase Inhibitor Therapy in Breast Cancer: Insights From a Multicenter Italian Study.

Journal: The breast journal
Published: November 25, 2024

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Journal: Cancers
Published: October 22, 2024

Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study.

Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study.

Journal: Frontiers in oncology
Published: August 05, 2019

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

Journal: Oncotarget
Published: October 13, 2016

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis.

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis.

Journal: OncoTargets and therapy
Published: July 23, 2016

Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.

Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.

Journal: Therapeutic advances in medical oncology
Published: May 03, 2014

New oral multitargeted antiangiogenics in non-small-cell lung cancer treatment.

New oral multitargeted antiangiogenics in non-small-cell lung cancer treatment.

Journal: Future oncology (London, England)
Published: June 01, 2012

Oral tyrosine kinase inhibitors in the first-line treatment of advanced non-small cell lung cancer.

Oral tyrosine kinase inhibitors in the first-line treatment of advanced non-small cell lung cancer.

Journal: Expert opinion on therapeutic targets
Published: March 27, 2012

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond.

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond.

Journal: Therapeutics and clinical risk management
Published: January 14, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026